HK1208367A1 - Nutritional product - Google Patents

Nutritional product

Info

Publication number
HK1208367A1
HK1208367A1 HK15109109.2A HK15109109A HK1208367A1 HK 1208367 A1 HK1208367 A1 HK 1208367A1 HK 15109109 A HK15109109 A HK 15109109A HK 1208367 A1 HK1208367 A1 HK 1208367A1
Authority
HK
Hong Kong
Prior art keywords
nutritional product
nutritional
product
Prior art date
Application number
HK15109109.2A
Other languages
English (en)
Chinese (zh)
Inventor
Maura Odonnell
Bridget Lambert
Patricia Wallis
Patricia Rutherford
Simon Heales
Sean-David Hughes
Helen Cross
Simon Eaton
Original Assignee
Vitaflo International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46641031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1208367(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitaflo International Ltd filed Critical Vitaflo International Ltd
Publication of HK1208367A1 publication Critical patent/HK1208367A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK15109109.2A 2012-06-15 2015-09-17 Nutritional product HK1208367A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1210699.3A GB201210699D0 (en) 2012-06-15 2012-06-15 Nutritional food
US201261704277P 2012-09-21 2012-09-21
PCT/GB2013/051561 WO2013186570A1 (en) 2012-06-15 2013-06-14 Nutritional product

Publications (1)

Publication Number Publication Date
HK1208367A1 true HK1208367A1 (en) 2016-03-04

Family

ID=46641031

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109109.2A HK1208367A1 (en) 2012-06-15 2015-09-17 Nutritional product

Country Status (13)

Country Link
US (2) US11344522B2 (fi)
EP (3) EP2861226B1 (fi)
JP (4) JP2015522256A (fi)
CN (2) CN107456450A (fi)
AU (5) AU2013276254A1 (fi)
BR (1) BR112014031302A2 (fi)
CA (1) CA2876286C (fi)
DK (1) DK2861226T3 (fi)
ES (1) ES2933408T3 (fi)
FI (1) FI2861226T3 (fi)
GB (1) GB201210699D0 (fi)
HK (1) HK1208367A1 (fi)
WO (1) WO2013186570A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201210699D0 (en) 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
CN105377252A (zh) 2013-03-14 2016-03-02 佛罗里达大学研究基金会 利用天然化合物和/或饮食调控癌症
WO2015127320A2 (en) * 2014-02-20 2015-08-27 Iycus, Llc Single serve beverage compositions
US20170202239A1 (en) * 2014-07-17 2017-07-20 The Nisshin Oillio Group, Ltd. Baked confectionery that substantially includes no flour
JP5881784B2 (ja) * 2014-07-17 2016-03-09 日清オイリオグループ株式会社 ゲル状乳化食品
JPWO2016010102A1 (ja) * 2014-07-17 2017-04-27 日清オイリオグループ株式会社 栄養組成物
JP6669761B2 (ja) * 2015-02-20 2020-03-18 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 不安神経症を治療するための中鎖脂肪酸及びそれらのトリグリセリド
US11020372B2 (en) 2015-03-24 2021-06-01 University Of Florida Research Foundation, Incorporated Dietary and natural product management of negative side effects of cancer treatment
AU2016283408A1 (en) * 2015-06-26 2018-01-04 University Of Florida Research Foundation, Incorporated Method of treating inflammation using natural compounds and/or diet
BR112018009288A8 (pt) 2015-12-04 2019-02-26 Nestec Sa composições de triglicerídeos de cadeia média
CA3041829A1 (en) * 2016-10-31 2018-05-03 The Cleveland Clinic Foundation Capric acid and myristic acid compositions for treating conditions
WO2018138620A1 (en) * 2017-01-29 2018-08-02 Gupta Samit Ketogenic nutritional composition and preparation method thereof
BR112019020785A2 (pt) * 2017-04-10 2020-04-28 Ucl Business Plc composição para uso no tratamento da epilepsia
US20200215013A1 (en) * 2017-06-29 2020-07-09 Vitaflo International Ltd Combination comprising decanoic acid for the treatment of epilepsy
WO2019147652A1 (en) * 2018-01-23 2019-08-01 The General Hospital Corporation Compositions and methods for improving mitochondrial function
KR102199688B1 (ko) 2018-11-20 2021-01-07 (주)엠디웰아이엔씨 수술 후 환자 영양불량 예방 또는 영양상태 회복 촉진용 식품 조성물
CN112006273B (zh) * 2020-06-05 2023-10-03 成都天一美膳营养食品有限公司 一种不生酮的健康减脂代餐粉及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2003425A1 (fr) 1968-03-07 1969-11-07 Unilever Nv Compositions grasses plastiques comestibles et procede pour les preparer
ATE303079T1 (de) 1999-02-05 2005-09-15 Baylor Res Inst Nahrungsergänzung oder pharmazeutische zusammensetzung enthaltend triglyceride bestehend aus fettsäuren mit 7 kohlenstoffatomen
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US20080009467A1 (en) * 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
EP2319508A1 (en) 2000-05-01 2011-05-11 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
WO2007001883A2 (en) 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
EP2457567B1 (en) 2007-09-19 2015-12-30 Nagoya Industrial Science Research Institute Agent having neurotrophic factor-like activity
US20110112010A1 (en) 2008-02-15 2011-05-12 The Government of the United States of America, as represented by The National Institutes of Health Octanoic acid formulations and methods of treatment using the same
CN102186364B (zh) * 2008-11-06 2013-10-02 日清奥利友集团株式会社 浓缩流质食品
WO2011040342A1 (ja) 2009-09-30 2011-04-07 日清オイリオグループ株式会社 パーキンソン病患者の内臓脂肪減少抑制剤
JP5749915B2 (ja) 2010-11-02 2015-07-15 花王株式会社 オートインデューサー−2阻害剤
GB201020133D0 (en) 2010-11-26 2011-01-12 Royal Holloway & Bedford New College Therapeutic use of compounds
GB201210699D0 (en) 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
US9833007B2 (en) 2013-11-15 2017-12-05 The Nisshin Oillio Group, Ltd. Soy milk and method for producing same
JPWO2016010102A1 (ja) 2014-07-17 2017-04-27 日清オイリオグループ株式会社 栄養組成物

Also Published As

Publication number Publication date
JP2021107394A (ja) 2021-07-29
EP4371612A2 (en) 2024-05-22
US11344522B2 (en) 2022-05-31
CA2876286A1 (en) 2013-12-19
BR112014031302A2 (pt) 2017-06-27
CA2876286C (en) 2021-03-16
AU2013276254A1 (en) 2014-12-18
EP2861226A1 (en) 2015-04-22
US20220273602A1 (en) 2022-09-01
AU2018200433A1 (en) 2018-02-08
AU2021202459A1 (en) 2021-05-20
DK2861226T3 (da) 2023-01-30
CN104519880A (zh) 2015-04-15
EP2861226B1 (en) 2022-11-02
WO2013186570A1 (en) 2013-12-19
GB201210699D0 (en) 2012-08-01
ES2933408T3 (es) 2023-02-08
AU2019226282A1 (en) 2019-09-26
AU2021202459B2 (en) 2022-07-21
AU2022253500B2 (en) 2024-05-02
JP2015522256A (ja) 2015-08-06
JP2018121635A (ja) 2018-08-09
AU2022253500A1 (en) 2022-11-17
CN107456450A (zh) 2017-12-12
JP2023100665A (ja) 2023-07-19
EP4162934A1 (en) 2023-04-12
US20150164840A1 (en) 2015-06-18
FI2861226T3 (fi) 2023-01-31

Similar Documents

Publication Publication Date Title
HK1208367A1 (en) Nutritional product
HK1245590A1 (zh) 口腔用產品
HK1204232A1 (en) Oral product
GB2503759B (en) Product pusher
ZA201401572B (en) Vegetable-based nutritional products
IL233907A0 (en) Products containing ice
GB201202206D0 (en) Meat product
PL2928306T3 (pl) Produkt czekoladowy
HK1205001A1 (en) Nutritional composition
GB201201904D0 (en) Product
GB201201900D0 (en) Product
ZA201407669B (en) Product packaging
ZA201405975B (en) Product
GB2510474B (en) Chocolate product
GB201413584D0 (en) Comestible product
GB201201908D0 (en) Product
GB201221262D0 (en) Product
GB201218360D0 (en) Product
GB201216881D0 (en) Product
GB201215997D0 (en) Product
GB201214674D0 (en) Product
GB201214669D0 (en) Product
GB201213430D0 (en) Product
GB201213428D0 (en) Product
GB201210747D0 (en) Product